Premarket Movers | Vir Biotech Soars 53%; Keysight Technologies Gains 15%; SanDisk Jumps over 2%; Novo Nordisk Falls 3%

Tiger Newspress
Yesterday

Vir Biotechnology, Inc. stock surgeed 53% in premarket trading after the small biotech company smashed Wall Street's fourth-quarter sales expectations and signed a collaboration deal with Astellas Pharma (ALPMY).

Electronic equipment maker Keysight Technologies forecast second-quarter profit ahead of Wall Street estimates, sending its shares up about 15% in premarket trading.

Storage shares rose in premarket trading. SanDisk up 2.55%; Seagate Tech, Western Digital up around 1%.

Novo Nordisk shares fell another 3% in premarket trading after closing 16% lower on Monday. Novo Nordisk's miss of a key goal in a late-stage comparison clinical trial of obesity drug CagriSema with Eli Lilly's Zepbound is a blow to the Danish drugmaker's long-term outlook, Citi analysts say.

Kratos Defense & Security Solutions reported fourth quarter results that exceeded analyst expectations, but shares fell 4.5% in premarket trading as the defense technology company’s first quarter revenue guidance disappointed investors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10